TPM3 and breast carcinoma: Using thromboSeq files, Yao et al. validated TPM3 by RT-qPCR as a platelet RNA marker for the detection of breast cancer, with an AUC of 0.971 on 109 healthy volunteer samples and 504 samples of patients with stage I–IV breast cancer [9].